(株)ミズホメディーの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4595/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2018/10/05 | 日証協 | 40,300株 | -2.18% | 0株 | -100% | 172,509株 | -0.92% | 2,044株 | -24.3% |
| 2018/09/28 | 日証協 | 41,200株 | +27.95% | 900株 | -89.89% | 174,113株 | +0.17% | 2,700株 | -12.9% |
| 2018/09/21 | 日証協 | 32,200株 | -3.59% | 8,900株 | +4350% | 173,813株 | -0.63% | 3,100株 | +10.71% |
| 2018/09/14 | 日証協 | 33,400株 | -20.85% | 200株 | -92.86% | 174,913株 | -5.25% | 2,800株 | -39.13% |
| 2018/09/07 | 日証協 | 42,200株 | -14.78% | 2,800株 | -79.04% | 184,613株 | -2.12% | 4,600株 | -96.15% |
| 2018/08/31 | 日証協 | 49,517株 | +4.91% | 13,361株 | +237.31% | 188,613株 | -3.68% | 119,500株 | +3.46% |
| 2018/08/24 | 日証協 | 47,200株 | -27.72% | 3,961株 | -83.05% | 195,813株 | -5.26% | 115,500株 | +59.78% |
| 2018/08/17 | 日証協 | 65,300株 | -7.64% | 23,373株 | +480.41% | 206,686株 | +2.84% | 72,285株 | -38.31% |
| 2018/08/10 | 日証協 | 70,700株 | +6.32% | 4,027株 | -41.64% | 200,976株 | -10.24% | 117,168株 | +171.82% |
| 2018/08/03 | 日証協 | 66,500株 | -0.3% | 6,900株 | +11.29% | 223,908株 | +6.12% | 43,105株 | -42.83% |
| 2018/07/27 | 日証協 | 66,700株 | -73.32% | 6,200株 | +158.33% | 211,003株 | -33.06% | 75,400株 | +20.06% |
| 2018/07/20 | 日証協 | 250,000株 | 0% | 2,400株 | 0% | 315,203株 | 0% | 62,800株 | 0% |
| 2018/07/13 | 日証協 | 258,700株 | +1.08% | 121,189株 | +434.11% | 323,492株 | -8.75% | 67,889株 | +667.28% |
| 2018/07/06 | 日証協 | 255,942株 | -0.99% | 22,690株 | -81.69% | 354,503株 | +2.06% | 8,848株 | -38.13% |
| 2018/06/29 | 日証協 | 258,500株 | -3.34% | 123,890株 | -46.06% | 347,343株 | -5.43% | 14,300株 | -91.45% |
| 2018/06/22 | 日証協 | 267,432株 | +227.57% | 229,684株 | +456% | 367,285株 | +26.31% | 167,200株 | +1044.89% |
| 2018/06/15 | 日証協 | 81,642株 | -7.85% | 41,310株 | -44.34% | 290,789株 | +37.43% | 14,604株 | -94.74% |
| 2018/06/08 | 日証協 | 88,600株 | +17.98% | 74,213株 | +30.2% | 211,585株 | +241.46% | 277,791株 | +195.31% |
| 2018/06/01 | 日証協 | 75,100株 | -62.07% | 57,000株 | +145.69% | 61,965株 | -25.75% | 94,067株 | +519.6% |
※株式分割は考慮していませんのでご注意ください。
Page Top